🇺🇸 FDA

Intelligence Platform

Patents

Browse 373 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6946247

RNAse probe protection assays in screening for modulators of immunoglobulin germline trans

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6887675

Tankyrase H, compositions involved in the cell cycle and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue May 03 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6824976

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6777179

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6759538

Substituted diphenyl heterocycles useful for treating HCV infection

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6737232

IAPs associated cell cycle proteins, compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6696263

PCNA associated cell cycle proteins, compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 24 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6667152

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6623961

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6617102

Tankyrase H, compositions involved in the cell cycle and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Sep 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6589725

Tankyrase H, compositions involved in the cell cycle and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6579674

Method for selective inactivation of viral replication

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6387658

PCNA-associated cell cycle proteins, compositions and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue May 14 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired